HLTH PDS
The Product Disclosure Statement (PDS) explains the fees, tax status and some of the risks.
Menu
The HLTH ETF invests in shares of international healthcare companies which offer growth ‘at a reasonable price’. Meaning, the ETF aims to invest in shares according to the common GARP methodology.
The HLTH ETF tracks The MarketGrader Developed Markets (ex-Australia) Health Care Net Return AUD Index – quite the mouthful. The index consists of 50 healthcare companies with the best growth at a reasonable price (GARP) attributes outside of Australia. The GARP properties focus on fundamentals across four categories: growth, value, profitability, and cash flow.
The index behind the HLTH ETF is well diversified across weightings, with the largest holdings often around 3% of the portfolio. Geographically, the holdings are primarily domiciled in the United States, consisting of 50% – 55% of the index.
To invest in any ASX ETF, you need to use create your own broker account and choose from over 400 ETFs.
But why bother do that when you can get everything done for you – for a simple, low, fee?
We manage ETF portfolios on behalf of 250+ Australian investors, with over $20 million invested.
Simple. Low cost. Transparent. Professional.
It’s called Rask Invest.
Click the button to discover the ETFs we own, and how it works.
*The warnings on this page are applied by our ETF research team. Please know that these warnings are based on quantitative metrics and our internal methodology. These risks are not exhaustive and therefore they should not be relied upon. Always read the PDS of the function and speak to your financial adviser before acting on this information.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024
